{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:26:10Z","timestamp":1785551170062,"version":"3.56.0"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Vet Emergen Crit Care"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate a clinical population of dogs exposed to selective serotonin reuptake inhibitor (<jats:styled-content style=\"fixed-case\">SSRI<\/jats:styled-content>) antidepressant medications and describe the clinical findings, epidemiological characteristics, outcome, and prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective study (February 1, 2005\u2013August 31, 2010).<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Animal poison control helpline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Animals<\/jats:title><jats:p>Three hundred thirteen dogs with presumed<jats:styled-content style=\"fixed-case\">SSRI<\/jats:styled-content>toxicosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements and Main Results<\/jats:title><jats:p>Dogs with presumptive<jats:styled-content style=\"fixed-case\">SSRI<\/jats:styled-content>medication toxicosis identified by a review of the electronic database of Pet Poison Helpline, an animal poison control center, were evaluated. No clinical signs were reported in 76.3% (239\/313) of cases. The remaining 23.6% (74\/313) of cases demonstrated the following clinical signs: neurological 79.7% (59\/74), gastrointestinal 25.6% (19\/74), cardiovascular 9.5% (7\/74), respiratory 8.2% (6\/74), and thermoregulatory 6.7% (5\/74). Of the dogs exhibiting neurological signs, 62.7% (37\/59) showed depression, 37.2% (22\/59) showed hyperactivity, 10.1% (6\/59) exhibited ataxia, and 1.7% (1\/59) showed other miscellaneous signs (eg, hyperesthesia). There was a significant difference between the dose ingested by symptomatic and asymptomatic dogs for fluoxetine (<jats:italic>P<\/jats:italic>= 0.0039), but not with any other<jats:styled-content style=\"fixed-case\">SSRI<\/jats:styled-content>. Ninety\u2010four patients were confirmed to have received veterinary care. In cases where duration of veterinary care was determined (55\/313), 67.2% (37\/55) of dogs were hospitalized and 32.7% (18\/55) treated as outpatients. The average duration of hospitalization was 18.5 hours, excluding outpatient visits. Of those patients that had complete follow\u2010up information available (136\/313), overall survival was 100%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The overall prognosis for animals with<jats:styled-content style=\"fixed-case\">SSRI<\/jats:styled-content>toxicosis is excellent with veterinary attention. Central nervous system depression was the most common clinical sign associated with<jats:styled-content style=\"fixed-case\">SSRI<\/jats:styled-content>toxicosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1476-4431.2012.00805.x","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T16:41:38Z","timestamp":1351615298000},"page":"674-681","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Retrospective evaluation of toxicosis from selective serotonin reuptake inhibitor antidepressants: 313 dogs (2005\u20132010)"],"prefix":"10.1111","volume":"22","author":[{"given":"Danielle E.","family":"Thomas","sequence":"first","affiliation":[{"name":"Section of Emergency and Critical Care Angell Animal Medical Center 350 S Huntington Ave Boston MA 02130"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Pet Poison Helpline, 8009 34th Ave South Ste 875 Bloomington MN 55425"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Hovda","sequence":"additional","affiliation":[{"name":"Pet Poison Helpline, 8009 34th Ave South Ste 875 Bloomington MN 55425"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2008.00944.x"},{"key":"e_1_2_12_3_1","first-page":"1070","volume-title":"Goldfrank's toxicologic emergencies","author":"Stork C","year":"2006"},{"key":"e_1_2_12_4_1","volume-title":"Health, United States, 2010: With Special Feature on Death and Dying","author":"National Center for Health Statistics","year":"2011"},{"key":"e_1_2_12_5_1","first-page":"18","article-title":"Effects of reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety","volume":"8","author":"Simpson BS","year":"2007","journal-title":"Vet Ther"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199000163-00002"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1954.sp005206"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1955.sp005437"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90671-O"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00004"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70203-3"},{"key":"e_1_2_12_12_1","first-page":"1","article-title":"Evidence for the existence of monoamine\u2010containing neurons in the central nervous system","volume":"62","author":"Dahlstr\u00f6m A","year":"1964","journal-title":"Acta Physiol Scand Suppl"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90506-5"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)70190-7"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000177642.89888.85"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818010-00005"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109"},{"key":"e_1_2_12_18_1","unstructured":"US Food andDrugAdministration.ElancoAnimalHealth. Freedom of Information summary\u2010OriginalNewAnimalDrugApplication;NADA141\u2013272 Reconcile Fluoxetine hydrochloride chewable tablets for dogs.2007. [Accessed 8\/2010]. Available at:http:\/\/www.fda.gov\/AnimalVeterinary\/Products\/ApprovedAnimalDrugProducts\/ucm2006464.htm."},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120037428"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199706000-00012"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.11.016"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2008.06.030"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701285289"},{"key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-3565(25)21773-6","article-title":"Sertraline, 1S,4S\u2010N\u2010methyl\u20104\u2010(3,4\u2010dichlorophenyl)\u20101,2,3,4\u2010tetrahydro\u20101\u2010naphthylamine, a new uptake inhibitor with selectivity for serotonin","volume":"226","author":"Koe BK","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/01480549809002220"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2000.216.1937"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90265-2"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-6757(94)90031-0"},{"key":"e_1_2_12_29_1","first-page":"195","volume-title":"Blackwell's Five\u2010Minute Veterinary Consult Clinical Companion: Small Animal Toxicology","author":"Osweiler GD","year":"2010"},{"key":"e_1_2_12_30_1","unstructured":"US Food andDrugAdministration.Celexa (citalopram hydrobromide)Tablets\/OralSolution NDA20\u2013822\/NDA21\u201304;ProposedLabelingText.Washington DC:2008. [accessed 8\/2010]. Available at:http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020822s037 021046s015lbl.pdf."},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2003.03005.x"},{"key":"e_1_2_12_32_1","volume-title":"Clinical Pharmacology of SSRIs","author":"Preskorn S","year":"1996"}],"container-title":["Journal of Veterinary Emergency and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-4431.2012.00805.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-4431.2012.00805.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T22:56:07Z","timestamp":1745103367000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-4431.2012.00805.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1476-4431.2012.00805.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-4431.2012.00805.x","archive":["Portico"],"relation":{},"ISSN":["1479-3261","1476-4431"],"issn-type":[{"value":"1479-3261","type":"print"},{"value":"1476-4431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]},"assertion":[{"value":"2011-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}